DADC
ASTH icon

D.A. Davidson & Co’s Astrana Health ASTH Stock Holding History

D.A. Davidson & Co’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-26,510
Closed -$822K – 1515
2025
Q1 		$822K Sell
26,510
-251
-0.9% -$8.36K 0.01% 840
2024
Q4 		$844K Buy
26,761
+196
+0.7% +$9.31K 0.01% 830
2024
Q3 		$1.54M Sell
26,565
-397
-1% -$19.5K 0.01% 634
2024
Q2 		$1.09M Sell
26,962
-80
-0.3% -$3.17K 0.01% 706
2024
Q1 		$1.14M Sell
27,042
-781
-3% -$30.5K 0.01% 697
2023
Q4 		$1.07M Sell
27,823
-1,734
-6% -$57.7K 0.01% 694
2023
Q3 		$912K Sell
29,557
-423
-1% -$14.6K 0.01% 707
2023
Q2 		$947K Buy
29,980
+1,306
+5% +$44.8K 0.01% 709
2023
Q1 		$1.05M Sell
28,674
-1,121
-4% -$39.2K 0.01% 656
2022
Q4 		$882K Buy
29,795
+548
+2% +$17.6K 0.01% 664
2022
Q3 		$1.14M Sell
29,247
-5,732
-16% -$262K 0.01% 550
2022
Q2 		$1.35M Sell
34,979
-392
-1% -$14.9K 0.02% 521
2022
Q1 		$1.71M Sell
35,371
-8,266
-19% -$426K 0.02% 491
2021
Q4 		$3.21M Sell
43,637
-485
-1% -$39.8K 0.03% 348
2021
Q3 		$4.02M Sell
44,122
-21,421
-33% -$1.82M 0.05% 297
2021
Q2 		$4.12M Buy
65,543
+20,240
+45% +$748K 0.05% 293
2021
Q1 		$1.23M Buy
+45,303
New +$1.09M 0.02% 532

Other funds holding ASTH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

D.A. Davidson & Co's ASTH Position: Q2 2025 in Review

D.A. Davidson & Co sold out of Astrana Health (ASTH) in Q2 2025, closing a stake of 26,510 shares — an estimated $822K sold.

D.A. Davidson & Co first reported a position in ASTH in Q1 2021 and held it in 17 quarters. The position peaked at $4.12M in Q2 2021. 162 funds tracked by Wall St. Rank hold ASTH as of Q2 2025.

  • D.A. Davidson & Co reported no remaining Astrana Health position as of Q2 2025 after selling out during the quarter.
  • D.A. Davidson & Co sold 26,510 Astrana Health shares in Q2 2025, an estimated $822K.
  • D.A. Davidson & Co first reported a position in Astrana Health in Q1 2021 and held it in 17 quarters.
  • D.A. Davidson & Co's Astrana Health position peaked at $4.12M in Q2 2021.
  • 162 funds tracked by Wall St. Rank held Astrana Health as of Q2 2025.

Based on D.A. Davidson & Co's 13F filing for Q2 2025, filed 30 Jul 2025.